financetom
Business
financetom
/
Business
/
GFL Environmental to Sell its Environmental Services Business for About $8 Billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GFL Environmental to Sell its Environmental Services Business for About $8 Billion
Jan 7, 2025 3:53 AM

06:23 AM EST, 01/07/2025 (MT Newswires) -- GFL Environmental ( GFL ) said Tuesday it has signed a deal with funds managed by Apollo Global Management ( APO ) and BC Partners to sell its environmental services operations for about $8 billion in enterprise value.

The company will keep $1.7 billion equity ownership in the business and anticipates realizing cash proceeds of about $6.2 billion net of the retained equity and taxes, it added.

GFL said it plans to use up to $3.75 billion of the net proceeds for the repayment of debt, stock buyback, and general corporate purposes.

GFL will maintain a 44% equity ownership in the business, while Apollo Funds and BC Partners will each have a 28% equity stake, according to GFL.

The deal, expected to close in Q1, is not subject to any financing requirements, the company said.

GFL shares rose over 2% in recent Tuesday premarket activity.

Price: 45.20, Change: +1.18, Percent Change: +2.68

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CBL & Associates Properties Buys Back $12.5 Million Block of Shares
CBL & Associates Properties Buys Back $12.5 Million Block of Shares
Oct 10, 2024
04:53 PM EDT, 10/10/2024 (MT Newswires) -- CBL & Associates Properties ( CBL ) repurchased 500,000 shares for $12.5 million in a privately negotiated block trade with a single investor. The trade wasn't part of an existing repurchase program, CBL said Thursday in a statement. The company said it completed the share buyback program of up to $25 million on...
Heron Therapeutics Reaffirms Supply of Ready-to-Administer Nausea Prevention Medications
Heron Therapeutics Reaffirms Supply of Ready-to-Administer Nausea Prevention Medications
Oct 10, 2024
04:53 PM EDT, 10/10/2024 (MT Newswires) -- Heron Therapeutics ( HRTX ) said Thursday it can continue supplying its ready-to-administer chemotherapy-induced and postoperative nausea and vomit prevention medications Cinvanti, Sustol, and Aponvie amid the expected shortage of intravenous fluids caused by Hurricane Helene. The expected disruption in IV fluid supply is due to the temporary closure of a major manufacturing...
Artizia Fiscal Second-Quarter Earnings and Revenue Beat Forecasts
Artizia Fiscal Second-Quarter Earnings and Revenue Beat Forecasts
Oct 10, 2024
04:53 PM EDT, 10/10/2024 (MT Newswires) -- Aritzia Inc. ( ATZAF ) after trade Thursday reported a fiscal second-quarter earnings and revenues beat, and provided a third quarter outlook lower than a consensus estimate from Capital IQ. The clothing retailer said its adjusted profit, which excludes most one-time items, rose to $24.5 million, or $0.21 per share, in the quarter...
Allakos Subcutaneous Therapy for Mast Cells-Related Diseases 'Well-Tolerated;' Shares Up After Hours
Allakos Subcutaneous Therapy for Mast Cells-Related Diseases 'Well-Tolerated;' Shares Up After Hours
Oct 10, 2024
04:55 PM EDT, 10/10/2024 (MT Newswires) -- Allakos ( ALLK ) said Thursday results of a phase 1 trial showed that a subcutaneously administered AK006, its investigational monoclonal antibody that selectively inhibits mast cells, was well-tolerated with a favorable safety profile. The company reported data from single dose subcutaneous AK006 up to 720 milligrams, with skin biopsies taken from treated...
Copyright 2023-2026 - www.financetom.com All Rights Reserved